EORTC-06083-LG

Clofarabine added to prephase and consolidation therapy in acute lymphoblastic leukemia in adults. A prospective randomized trial.
Study documentation
Trial StatusRecruiting
DatesDate of activation: 19-Dec-11
Data management at EORTCMailbox
Phase2-3
Randomized trial
Type-
Targeted Sample sizeEORTC Groups: 15 - All Groups: 340
Number of steps1
DrugMercaptopurine
Tioguanine
Cytarabine
Daunorubicin
Doxorubicin
Etoposide
Leucovorin
Methotrexate
Prednisolone
Prednisone
Vinblastine
Vincristine
Vindesine
Clofarabine
Dexamethasone
Study StaffJean-Pierre Marie
Study Coordinator - Assistance Publique - Hopitaux de Paris - Hopital Saint Antoine, Paris
Stefan Suciu
Statistician - EORTC Headquarters, Brussels
Liv Meert
Data Manager - EORTC Headquarters, Brussels
liv.meert (at) eortc.be - +32
Gaetan de Schaetzen
Project Manager - EORTC Headquarters, Brussels
gaetan.deschaetzen (at) eortc.be - +32
Type of cancerAcute Lymphocytic Leukemia
Participating GroupsHemato-Oncologie Volwassenen Nederland(Coordinating Group)
EORTC Leukemia Group
Centers authorized by EORTC
Protocol summaryClinicalTrials.gov
NCT number
EudraCT2008-005798-36